Valeant Pharmaceuticals International Inc. defended itself Monday, saying it had properly accounted for its much-debated relationships with specialty pharmacies and had found "no evidence whatsoever" of any illegal activity at the company.
At the same time, Valeant VRX, -5.24% said it created a new board committee to review questions raised about the company’s relationship with Philidor Rx Services LLC and other specialty pharmacies since Valeant disclosed them a week ago.
Read Full Article »